TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

Nanoparticle therapy brings new hope to prostate cancer patients, offering targeted treatment that improves outcomes with fewer side effects.

After decades of research, the field of focused ultrasound is exploding with new advances — promising safer, more effective ...

Prostate cancer is the second leading cause of cancer death among American men. A ground-breaking study, conducted by ...

SIGNIFICANT milestone in the health sector has been achieved as Kairuki Hospital introduces High-Intensity Focused Ultrasound ...

A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, ...

A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. The call will also be broadcast live and archived on ...

Transrectal ultrasound (TRUS) examination of the prostate is the established technique used to obtain systematic core biopsies of prostatic tissue for histological examination. This is usually to ...

Follow-up tests included a prostate MRI, which showed a suspicious spot for cancer on one side of the prostate. An ...